I think most people on the forum have heard of the dreaded MRSA bacterium. It is very common in hospitals and every doctor fears that it may infect his/her patients. There have been many studies and alarming news articles published on the resilience of MRSA and the lack of available treatment options. Copper sulfate/chloride is one of the few effective methods of dealing with contaminated surfaces and there are several clinical trials trying to turn the copper substance into a drug for treating infected humans as well.
Well, it looks like once again the old dog aspirin has a new trick up its sleeve. This study shows that a low dose of aspirin may be an effective method of preventing infections with (and deaths from) this dreaded bacterium.
Keep in mind that aspirin is an actual hormone in plants and its primarily responsible for defense from ANY pathogen, so these effects in humans should not be completely surprising.
Low-Dose Acetylsalicylic Acid Treatment and Impact on Short-... : Critical Care Medicine
http://well.blogs.nytimes.com/2016/02/03/aspirin-may-protect-against-staph-blood-infections/?_r=1
"...Taking a daily low-dose aspirin has been shown to reduce the risk for heart attack and stroke, and possibly the risk for certain cancers. Now researchers have found another possible benefit: protection against dying from a Staphylococcus aureus blood infection. Swiss scientists followed 838 cases of S. aureus infection from 2001 through 2013. From the group, they selected 157 who were taking aspirin and matched them with 157 controls, similar in age, severity of infection, treatments undergone and various other health and behavioral characteristics, but who were not taking low-dose aspirin. The study is in Critical Care Medicine. At the end of 30 days, 27.4 percent of the controls had died, but only 12.1 percent of those on aspirin had died. After controlling for other factors, taking low-dose aspirin (usually sold in doses of 81 milligrams) was associated with a 42 percent lower risk of death."
Well, it looks like once again the old dog aspirin has a new trick up its sleeve. This study shows that a low dose of aspirin may be an effective method of preventing infections with (and deaths from) this dreaded bacterium.
Keep in mind that aspirin is an actual hormone in plants and its primarily responsible for defense from ANY pathogen, so these effects in humans should not be completely surprising.
Low-Dose Acetylsalicylic Acid Treatment and Impact on Short-... : Critical Care Medicine
http://well.blogs.nytimes.com/2016/02/03/aspirin-may-protect-against-staph-blood-infections/?_r=1
"...Taking a daily low-dose aspirin has been shown to reduce the risk for heart attack and stroke, and possibly the risk for certain cancers. Now researchers have found another possible benefit: protection against dying from a Staphylococcus aureus blood infection. Swiss scientists followed 838 cases of S. aureus infection from 2001 through 2013. From the group, they selected 157 who were taking aspirin and matched them with 157 controls, similar in age, severity of infection, treatments undergone and various other health and behavioral characteristics, but who were not taking low-dose aspirin. The study is in Critical Care Medicine. At the end of 30 days, 27.4 percent of the controls had died, but only 12.1 percent of those on aspirin had died. After controlling for other factors, taking low-dose aspirin (usually sold in doses of 81 milligrams) was associated with a 42 percent lower risk of death."
